{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:00:34Z","timestamp":1790910034719,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["675527"],"award-info":[{"award-number":["675527"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","award":["personal PhD grant"],"award-info":[{"award-number":["personal PhD grant"]}],"id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obstructive arterial disease is a major cause of morbidity and mortality in the developed world. Venous bypass graft surgery is one of the most frequently used revascularization strategies despite its considerable short and long time failure rate. Due to vessel wall remodeling, inflammation, intimal hyperplasia, and accelerated atherosclerosis, vein grafts may (ultimately) fail to revascularize tissues downstream to occlusive atherosclerotic lesions. In the past decades, little has changed in the prevention of vein graft failure (VGF) although new insights in the role of innate and adaptive immunity in VGF have emerged. In this review, we discuss the pathophysiological mechanisms underlying the development of VGF, emphasizing the role of immune response and associated factors related to VG remodeling and failure. Moreover, we discuss potential therapeutic options that can improve patency based on data from both preclinical studies and the latest clinical trials. This review contributes to the insights in the role of immunomodulation in vein graft failure in humans. We describe the effects of immune cells and related factors in early (thrombosis), intermediate (inward remodeling and intimal hyperplasia), and late (intimal hyperplasia and accelerated atherosclerosis) failure based on both preclinical (mouse) models and clinical data.<\/jats:p>","DOI":"10.1007\/s12265-020-10001-y","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T01:02:17Z","timestamp":1592269337000},"page":"100-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Role of Immunomodulation in Vein Graft Remodeling and Failure"],"prefix":"10.1007","volume":"14","author":[{"given":"Fabiana","family":"Baganha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H. A.","family":"Quax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet R.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"issue":"7","key":"10001_CR1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/jama.1973.03220070046012","volume":"223","author":"HE Garrett","year":"1973","unstructured":"Garrett, H. E., Dennis, E. W., & DeBakey, M. E. (1973). Aortocoronary bypass with saphenous vein graft: seven-year follow-up. JAMA, 223(7), 792\u2013794.","journal-title":"JAMA"},{"issue":"2","key":"10001_CR2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0022-5223(19)42599-3","volume":"58","author":"RG Favaloro","year":"1969","unstructured":"Favaloro, R. G. (1969). Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique. The Journal of Thoracic and Cardiovascular Surgery, 58(2), 178\u2013185.","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"8922","key":"10001_CR3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","volume":"344","author":"S Yusuf","year":"1994","unstructured":"Yusuf, S., et al. (1994). Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet, 344(8922), 563\u2013570.","journal-title":"Lancet"},{"issue":"5","key":"10001_CR4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0735-1097(94)00518-U","volume":"25","author":"KB Davis","year":"1995","unstructured":"Davis, K. B., et al. (1995). Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary artery surgery study. Journal of the American College of Cardiology, 25(5), 1000\u20131009.","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10001_CR5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrcardio.2016.76","volume":"13","author":"MR de Vries","year":"2016","unstructured":"de Vries, M. R., et al. (2016). Vein graft failure: from pathophysiology to clinical outcomes. Nature Reviews. Cardiology, 13(8), 451\u2013470.","journal-title":"Nature Reviews. Cardiology"},{"issue":"3","key":"10001_CR6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jvs.2009.07.102","volume":"51","author":"CD Owens","year":"2010","unstructured":"Owens, C. D. (2010). Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. Journal of Vascular Surgery, 51(3), 736\u2013746.","journal-title":"Journal of Vascular Surgery"},{"issue":"4 Pt 1","key":"10001_CR7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0002-8703(87)90780-0","volume":"114","author":"AE Walts","year":"1987","unstructured":"Walts, A. E., Fishbein, M. C., & Matloff, J. M. (1987). Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years\u2019 experience. American Heart Journal, 114(4 Pt 1), 718\u2013723.","journal-title":"American Heart Journal"},{"issue":"21","key":"10001_CR8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM198411223112101","volume":"311","author":"L Campeau","year":"1984","unstructured":"Campeau, L., et al. (1984). The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. The New England Journal of Medicine, 311(21), 1329\u20131332.","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10001_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jss.2007.03.062","volume":"142","author":"ZN Kon","year":"2007","unstructured":"Kon, Z. N., et al. (2007). The role of preexisting pathology in the development of neointimal hyperplasia in coronary artery bypass grafts. The Journal of Surgical Research, 142(2), 351\u2013356.","journal-title":"The Journal of Surgical Research"},{"key":"10001_CR10","doi-asserted-by":"crossref","unstructured":"Dashwood, M.R., et al. (2004). Hypothesis: a potential role for the vasa vasorum in the maintenance of vein graft patency. Angiology, 55(4), 385\u2013395.","DOI":"10.1177\/000331970405500405"},{"issue":"4","key":"10001_CR11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ejcts\/ezt560","volume":"45","author":"S Verma","year":"2013","unstructured":"Verma, S., et al. (2013). Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study\u2020. European Journal of Cardio-Thoracic Surgery, 45(4), 717\u2013725.","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"1","key":"10001_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jvs.2013.06.004","volume":"60","author":"MJ Osgood","year":"2014","unstructured":"Osgood, M. J., et al. (2014). Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein. Journal of Vascular Surgery, 60(1), 202\u2013211.","journal-title":"Journal of Vascular Surgery"},{"issue":"4","key":"10001_CR13","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1093\/ejcts\/ezs402","volume":"42","author":"R Stigler","year":"2012","unstructured":"Stigler, R., et al. (2012). The impact of distension pressure on acute endothelial cell loss and neointimal proliferation in saphenous vein grafts. European Journal of Cardio-Thoracic Surgery, 42(4), e74\u2013e79.","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"4","key":"10001_CR14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jvs.2006.06.005","volume":"44","author":"CD Owens","year":"2006","unstructured":"Owens, C. D., et al. (2006). Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness. Journal of Vascular Surgery, 44(4), 740\u2013746.","journal-title":"Journal of Vascular Surgery"},{"issue":"3","key":"10001_CR15","first-page":"393","volume":"105","author":"PB Dobrin","year":"1989","unstructured":"Dobrin, P. B., Littooy, F. N., & Endean, E. D. (1989). Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery, 105(3), 393\u2013400.","journal-title":"Surgery"},{"issue":"2","key":"10001_CR16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.coph.2012.01.005","volume":"12","author":"H Weaver","year":"2012","unstructured":"Weaver, H., et al. (2012). Oxidative stress and vein graft failure: a focus on NADH oxidase, nitric oxide and eicosanoids. Current Opinion in Pharmacology, 12(2), 160\u2013165.","journal-title":"Current Opinion in Pharmacology"},{"key":"10001_CR17","doi-asserted-by":"crossref","unstructured":"Gooch, K. J., et al. (2018). Biomechanics and mechanobiology of saphenous vein grafts. Journal of Biomechanical Engineering, 140(2), 804\u2013816.","DOI":"10.1115\/1.4038705"},{"issue":"2","key":"10001_CR18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.athoracsur.2011.10.035","volume":"93","author":"MS Khaleel","year":"2012","unstructured":"Khaleel, M. S., et al. (2012). High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. The Annals of Thoracic Surgery, 93(2), 552\u2013558.","journal-title":"The Annals of Thoracic Surgery"},{"issue":"2","key":"10001_CR19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0003-4975(03)00433-8","volume":"76","author":"M Chello","year":"2003","unstructured":"Chello, M., et al. (2003). Pressure distension stimulates the expression of endothelial adhesion molecules in the human saphenous vein graft. The Annals of Thoracic Surgery, 76(2), 453\u2013458.","journal-title":"The Annals of Thoracic Surgery"},{"issue":"6","key":"10001_CR20","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.athoracsur.2004.12.054","volume":"79","author":"JV Manchio","year":"2005","unstructured":"Manchio, J. V., et al. (2005). Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery. The Annals of Thoracic Surgery, 79(6), 1991\u20131998.","journal-title":"The Annals of Thoracic Surgery"},{"issue":"2","key":"10001_CR21","first-page":"95","volume":"2","author":"DR Weiss","year":"2009","unstructured":"Weiss, D. R., et al. (2009). Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. International Journal of Clinical and Experimental Medicine, 2(2), 95\u2013113.","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"8","key":"10001_CR22","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","volume":"27","author":"N Mackman","year":"2007","unstructured":"Mackman, N., Tilley, R. E., & Key, N. S. (2007). Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(8), 1687\u20131693.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"3","key":"10001_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/bjs.1800780310","volume":"78","author":"T Yukizane","year":"1991","unstructured":"Yukizane, T., et al. (1991). Isotopic study of the effects of platelets on development of intimal thickening in autologous vein grafts in dogs. The British Journal of Surgery, 78(3), 297\u2013302.","journal-title":"The British Journal of Surgery"},{"issue":"3","key":"10001_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3346\/jkms.2000.15.3.273","volume":"15","author":"JK Cha","year":"2000","unstructured":"Cha, J. K., et al. (2000). Activated platelets induce secretion of interleukin-1beta, monocyte chemotactic protein-1, and macrophage inflammatory protein-1alpha and surface expression of intercellular adhesion molecule-1 on cultured endothelial cells. Journal of Korean Medical Science, 15(3), 273\u2013278.","journal-title":"Journal of Korean Medical Science"},{"issue":"2","key":"10001_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2015.164","volume":"13","author":"K Yahagi","year":"2016","unstructured":"Yahagi, K., et al. (2016). Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nature Reviews. Cardiology, 13(2), 79\u201398.","journal-title":"Nature Reviews. Cardiology"},{"issue":"6","key":"10001_CR26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000054091","volume":"37","author":"M Kalra","year":"2000","unstructured":"Kalra, M., & Miller, V. M. (2000). Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. Journal of Vascular Research, 37(6), 576\u2013584.","journal-title":"Journal of Vascular Research"},{"issue":"Suppl 1","key":"10001_CR27","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.2310\/6670.2008.00083","volume":"17","author":"SA Berceli","year":"2009","unstructured":"Berceli, S. A., et al. (2009). Hemodynamically driven vein graft remodeling: a systems biology approach. Vascular, 17(Suppl 1), S2\u2013S9.","journal-title":"Vascular"},{"issue":"5","key":"10001_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.amjsurg.2003.07.023","volume":"186","author":"KJ Woodside","year":"2003","unstructured":"Woodside, K. J., et al. (2003). Altered expression of vascular endothelial growth factor and its receptors in normal saphenous vein and in arterialized and stenotic vein grafts. American Journal of Surgery, 186(5), 561\u2013568.","journal-title":"American Journal of Surgery"},{"issue":"4","key":"10001_CR29","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.athoracsur.2004.02.066","volume":"78","author":"R Friedl","year":"2004","unstructured":"Friedl, R., et al. (2004). Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery. The Annals of Thoracic Surgery, 78(4), 1312\u20131318.","journal-title":"The Annals of Thoracic Surgery"},{"issue":"7","key":"10001_CR30","first-page":"1060","volume":"117","author":"WJ You","year":"2004","unstructured":"You, W. J., Xiao, M. D., & Yuan, Z. X. (2004). Significance of changes in transforming growth factor-beta mRNA levels in autogenous vein grafts. Chinese Medical Journal, 117(7), 1060\u20131065.","journal-title":"Chinese Medical Journal"},{"issue":"5","key":"10001_CR31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jvs.2008.12.020","volume":"49","author":"RD Kenagy","year":"2009","unstructured":"Kenagy, R. D., et al. (2009). Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. Journal of Vascular Surgery, 49(5), 1282\u20131288.","journal-title":"Journal of Vascular Surgery"},{"issue":"2","key":"10001_CR32","first-page":"236","volume":"1","author":"JH Lardenoye","year":"2005","unstructured":"Lardenoye, J. H., et al. (2005). Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo. EuroIntervention, 1(2), 236\u2013243.","journal-title":"EuroIntervention"},{"issue":"1","key":"10001_CR33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2006.08.017","volume":"193","author":"NA Turner","year":"2007","unstructured":"Turner, N. A., et al. (2007). Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis, 193(1), 36\u201343.","journal-title":"Atherosclerosis"},{"issue":"11 Suppl","key":"10001_CR34","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1161\/CIRCULATIONAHA.110.012732","volume":"124","author":"SJ George","year":"2011","unstructured":"George, S. J., et al. (2011). Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation, 124(11 Suppl), S135\u2013S142.","journal-title":"Circulation"},{"issue":"3","key":"10001_CR35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.CIR.101.3.296","volume":"101","author":"SJ George","year":"2000","unstructured":"George, S. J., et al. (2000). Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation, 101(3), 296\u2013304.","journal-title":"Circulation"},{"issue":"10","key":"10001_CR36","doi-asserted-by":"crossref","first-page":"e47134","DOI":"10.1371\/journal.pone.0047134","volume":"7","author":"MR de Vries","year":"2012","unstructured":"de Vries, M. R., et al. (2012). Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression. PLoS One, 7(10), e47134.","journal-title":"PLoS One"},{"issue":"7","key":"10001_CR37","doi-asserted-by":"crossref","first-page":"e41857","DOI":"10.1371\/journal.pone.0041857","volume":"7","author":"DX Sun","year":"2012","unstructured":"Sun, D. X., et al. (2012). Nanoparticle-mediated local delivery of an antisense TGF-beta1 construct inhibits intimal hyperplasia in autogenous vein grafts in rats. PLoS One, 7(7), e41857.","journal-title":"PLoS One"},{"issue":"6","key":"10001_CR38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/ATVBAHA.107.140046","volume":"27","author":"WP Fay","year":"2007","unstructured":"Fay, W. P., Garg, N., & Sunkar, M. (2007). Vascular functions of the plasminogen activation system. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(6), 1231\u20131237.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10001_CR39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jvs.2009.09.026","volume":"51","author":"D Eefting","year":"2010","unstructured":"Eefting, D., et al. (2010). In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. Journal of Vascular Surgery, 51(2), 429\u2013437.","journal-title":"Journal of Vascular Surgery"},{"issue":"2","key":"10001_CR40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvq203","volume":"88","author":"D Eefting","year":"2010","unstructured":"Eefting, D., et al. (2010). A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease. Cardiovascular Research, 88(2), 367\u2013375.","journal-title":"Cardiovascular Research"},{"issue":"4","key":"10001_CR41","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.103.4.562","volume":"103","author":"PH Quax","year":"2001","unstructured":"Quax, P. H., et al. (2001). Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. Circulation, 103(4), 562\u2013569.","journal-title":"Circulation"},{"issue":"6","key":"10001_CR42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/joim.12679","volume":"282","author":"KH Simons","year":"2017","unstructured":"Simons, K. H., et al. (2017). A protective role of IRF3 and IRF7 signalling downstream TLRs in the development of vein graft disease via type I interferons. Journal of Internal Medicine, 282(6), 522\u2013536.","journal-title":"Journal of Internal Medicine"},{"key":"10001_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2018.06.001","volume":"121","author":"KH Simons","year":"2018","unstructured":"Simons, K. H., et al. (2018). The protective role of Toll-like receptor 3 and type-I interferons in the pathophysiology of vein graft disease. Journal of Molecular and Cellular Cardiology, 121, 16\u201324.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"13","key":"10001_CR44","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.4103\/0366-6999.208246","volume":"130","author":"R Dong","year":"2017","unstructured":"Dong, R., et al. (2017). MiR-551b-5p contributes to pathogenesis of vein graft failure via upregulating early growth response-1 expression. Chinese Medical Journal, 130(13), 1578\u20131585.","journal-title":"Chinese Medical Journal"},{"issue":"3","key":"10001_CR45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.RES.0000112405.61577.95","volume":"94","author":"E Harja","year":"2004","unstructured":"Harja, E., et al. (2004). Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circulation Research, 94(3), 333\u2013339.","journal-title":"Circulation Research"},{"issue":"22","key":"10001_CR46","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/eurheartj\/eht105","volume":"34","author":"RA McDonald","year":"2013","unstructured":"McDonald, R. A., et al. (2013). miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. European Heart Journal, 34(22), 1636\u20131643.","journal-title":"European Heart Journal"},{"key":"10001_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijcard.2016.01.006","volume":"208","author":"XW Wang","year":"2016","unstructured":"Wang, X. W., et al. (2016). MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts. International Journal of Cardiology, 208, 79\u201386.","journal-title":"International Journal of Cardiology"},{"issue":"10","key":"10001_CR48","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.20254","volume":"13","author":"XW Wang","year":"2017","unstructured":"Wang, X. W., et al. (2017). Adenovirus-mediated gene transfer of microRNA-21 sponge inhibits neointimal hyperplasia in rat vein grafts. International Journal of Biological Sciences, 13(10), 1309\u20131319.","journal-title":"International Journal of Biological Sciences"},{"issue":"4","key":"10001_CR49","doi-asserted-by":"crossref","first-page":"e0154274","DOI":"10.1371\/journal.pone.0154274","volume":"11","author":"C Emanueli","year":"2016","unstructured":"Emanueli, C., et al. (2016). Coronary artery-bypass-graft surgery increases the plasma concentration of exosomes carrying a cargo of cardiac microRNAs: an example of exosome trafficking out of the human heart with potential for cardiac biomarker discovery. PLoS One, 11(4), e0154274.","journal-title":"PLoS One"},{"key":"10001_CR50","doi-asserted-by":"crossref","unstructured":"Goossens, E. A. C., et al. (2019). miRMap: profiling 14q32 microRNA expression and DNA methylation throughout the human vasculature. Frontiers in Cardiovascular Medicine, 113(6), 1\u201322.","DOI":"10.3389\/fcvm.2019.00113"},{"issue":"5","key":"10001_CR51","first-page":"671","volume":"14","author":"JW Butany","year":"1998","unstructured":"Butany, J. W., David, T. E., & Ojha, M. (1998). Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses. The Canadian Journal of Cardiology, 14(5), 671\u2013677.","journal-title":"The Canadian Journal of Cardiology"},{"issue":"4","key":"10001_CR52","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jvs.2011.04.039","volume":"54","author":"K Moreno","year":"2011","unstructured":"Moreno, K., et al. (2011). Circulating inflammatory cells are associated with vein graft stenosis. Journal of Vascular Surgery, 54(4), 1124\u20131130.","journal-title":"Journal of Vascular Surgery"},{"issue":"6","key":"10001_CR53","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jcin.2011.12.017","volume":"5","author":"SK Yazdani","year":"2012","unstructured":"Yazdani, S. K., et al. (2012). Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions. JACC. Cardiovascular Interventions, 5(6), 666\u2013674.","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"1","key":"10001_CR54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/joim.12821","volume":"285","author":"MR de Vries","year":"2019","unstructured":"de Vries, M. R., et al. (2019). Blockade of vascular endothelial growth factor receptor 2 inhibits intraplaque haemorrhage by normalization of plaque neovessels. Journal of Internal Medicine, 285(1), 59\u201374.","journal-title":"Journal of Internal Medicine"},{"issue":"2","key":"10001_CR55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1160\/TH07-06-0387","volume":"99","author":"B Dorweiler","year":"2008","unstructured":"Dorweiler, B., et al. (2008). Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thrombosis and Haemostasis, 99(2), 373\u2013381.","journal-title":"Thrombosis and Haemostasis"},{"issue":"24","key":"10001_CR56","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa035655","volume":"349","author":"FD Kolodgie","year":"2003","unstructured":"Kolodgie, F. D., et al. (2003). Intraplaque hemorrhage and progression of coronary atheroma. The New England Journal of Medicine, 349(24), 2316\u20132325.","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10001_CR57","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/ATVBAHA.111.223271","volume":"31","author":"JC Karper","year":"2011","unstructured":"Karper, J. C., et al. (2011). Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 1033\u20131040.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10001_CR58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jvs.2012.07.007","volume":"57","author":"BT Nguyen","year":"2013","unstructured":"Nguyen, B. T., et al. (2013). Perivascular innate immune events modulate early murine vein graft adaptations. Journal of Vascular Surgery, 57(2), 486\u2013492 e2.","journal-title":"Journal of Vascular Surgery"},{"issue":"25","key":"10001_CR59","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1161\/CIRCULATIONAHA.106.619502","volume":"114","author":"A Schepers","year":"2006","unstructured":"Schepers, A., et al. (2006). Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3\u2013Leiden transgenic mice. Circulation, 114(25), 2831\u20132838.","journal-title":"Circulation"},{"issue":"1","key":"10001_CR60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2011.10.021","volume":"220","author":"PA Krijnen","year":"2012","unstructured":"Krijnen, P. A., et al. (2012). C1-esterase inhibitor protects against early vein graft remodeling under arterial blood pressure. Atherosclerosis, 220(1), 86\u201392.","journal-title":"Atherosclerosis"},{"key":"10001_CR61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.avsg.2016.10.033","volume":"41","author":"K Kupreishvili","year":"2017","unstructured":"Kupreishvili, K., et al. (2017). Arterial blood pressure induces transient C4b-binding protein in human saphenous vein grafts. Annals of Vascular Surgery, 41, 259\u2013264.","journal-title":"Annals of Vascular Surgery"},{"issue":"10","key":"10001_CR62","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jcmm.12357","volume":"18","author":"A Wezel","year":"2014","unstructured":"Wezel, A., et al. (2014). Complement factor C5a induces atherosclerotic plaque disruptions. Journal of Cellular and Molecular Medicine, 18(10), 2020\u20132030.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"10001_CR63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cvr\/cvs312","volume":"97","author":"MR de Vries","year":"2013","unstructured":"de Vries, M. R., et al. (2013). Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease. Cardiovascular Research, 97(2), 311\u2013320.","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10001_CR64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jtcvs.2010.08.035","volume":"142","author":"PK Smith","year":"2011","unstructured":"Smith, P. K., et al. (2011). Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. The Journal of Thoracic and Cardiovascular Surgery, 142(1), 89\u201398.","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"key":"10001_CR65","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.7717\/peerj.1192","volume":"3","author":"J Wu","year":"2015","unstructured":"Wu, J., et al. (2015). Perivascular mast cells regulate vein graft neointimal formation and remodeling. PeerJ, 3, e1192.","journal-title":"PeerJ"},{"issue":"4","key":"10001_CR66","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.athoracsur.2005.09.073","volume":"81","author":"A Schlitt","year":"2006","unstructured":"Schlitt, A., et al. (2006). Neutrophil adherence to activated saphenous vein and mammary endothelium after graft preparation. The Annals of Thoracic Surgery, 81(4), 1262\u20131268.","journal-title":"The Annals of Thoracic Surgery"},{"key":"10001_CR67","doi-asserted-by":"crossref","unstructured":"Trocha, K. M., et al. (2019). Short-term preoperative protein restriction attenuates vein graft disease via induction of cystathionine upsilon-lyase. Cardiovascular Research, 116(2), 416\u2013428.","DOI":"10.1093\/cvr\/cvz086"},{"issue":"6","key":"10001_CR68","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1160\/TH03-04-0226","volume":"90","author":"CJ Esposito","year":"2003","unstructured":"Esposito, C. J., et al. (2003). Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery. Thrombosis and Haemostasis, 90(6), 1128\u20131134.","journal-title":"Thrombosis and Haemostasis"},{"issue":"5","key":"10001_CR69","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1067\/mva.2001.118590","volume":"34","author":"MH Eslami","year":"2001","unstructured":"Eslami, M. H., et al. (2001). Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury? Journal of Vascular Surgery, 34(5), 923\u2013929.","journal-title":"Journal of Vascular Surgery"},{"issue":"3","key":"10001_CR70","first-page":"e001970","volume":"11","author":"JP Rehfuss","year":"2018","unstructured":"Rehfuss, J. P., et al. (2018). Hyperacute monocyte gene response patterns are associated with lower extremity vein bypass graft failure. Circulation: Genomic and Precision Medicine, 11(3), e001970.","journal-title":"Circulation: Genomic and Precision Medicine"},{"key":"10001_CR71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fcvm.2019.00077","volume":"6","author":"KH Simons","year":"2019","unstructured":"Simons, K. H., et al. (2019). CD8+ T cells protect during vein graft disease development. Frontiers in Cardiovascular Medicine, 6, 77.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"23","key":"10001_CR72","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1161\/CIRCULATIONAHA.106.675462","volume":"115","author":"E Fung","year":"2007","unstructured":"Fung, E., et al. (2007). Delta-like 4 induces notch signaling in macrophages: implications for inflammation. Circulation, 115(23), 2948\u20132956.","journal-title":"Circulation"},{"issue":"11","key":"10001_CR73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/ATVBAHA.115.305516","volume":"35","author":"J Koga","year":"2015","unstructured":"Koga, J., et al. (2015). Macrophage notch ligand delta-like 4 promotes vein graft lesion development: implications for the treatment of vein graft failure. Arteriosclerosis, Thrombosis, and Vascular Biology, 35(11), 10.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10001_CR74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12964-017-0214-x","volume":"16","author":"S Pagie","year":"2018","unstructured":"Pagie, S., Gerard, N., & Charreau, B. (2018). Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis. Cell Communication and Signaling: CCS, 16(1), 4.","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"10","key":"10001_CR75","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/ATVBAHA.116.306926","volume":"36","author":"T Nakano","year":"2016","unstructured":"Nakano, T., et al. (2016). Delta-like ligand 4-notch signaling in macrophage activation. Arteriosclerosis, Thrombosis, and Vascular Biology, 36(10), 2038\u20132047.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"6","key":"10001_CR76","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41569-019-0164-7","volume":"16","author":"KH Simons","year":"2019","unstructured":"Simons, K. H., et al. (2019). T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword. Nature Reviews. Cardiology, 16(6), 325\u2013343.","journal-title":"Nature Reviews. Cardiology"},{"issue":"5","key":"10001_CR77","doi-asserted-by":"crossref","first-page":"e20214","DOI":"10.1371\/journal.pone.0020214","volume":"6","author":"PC Dimayuga","year":"2011","unstructured":"Dimayuga, P. C., et al. (2011). Enhanced neointima formation following arterial injury in immune deficient Rag-1-\/- mice is attenuated by adoptive transfer of CD8 T cells. PLoS One, 6(5), e20214.","journal-title":"PLoS One"},{"key":"10001_CR78","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2013.08.009","volume":"64","author":"MR de Vries","year":"2013","unstructured":"de Vries, M. R., et al. (2013). C57BL\/6 NK cell gene complex is crucially involved in vascular remodeling. Journal of Molecular and Cellular Cardiology, 64, 51\u201358.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10001_CR79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0967-2109(00)00102-2","volume":"9","author":"SM Cherian","year":"2001","unstructured":"Cherian, S. M., et al. (2001). Immunohistochemical and ultrastructural evidence that dendritic cells infiltrate stenotic aortocoronary saphenous vein bypass grafts. Cardiovascular Surgery, 9, 6.","journal-title":"Cardiovascular Surgery"},{"issue":"3","key":"10001_CR80","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ijcard.2012.12.085","volume":"168","author":"MM Ewing","year":"2013","unstructured":"Ewing, M. M., et al. (2013). T-cell co-stimulation by CD28-CD80\/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development. International Journal of Cardiology, 168(3), 1965\u20131974.","journal-title":"International Journal of Cardiology"},{"key":"10001_CR81","doi-asserted-by":"crossref","unstructured":"Rothermel, A. L., et al. (2004). Endothelial cells present antigens in vivo. BMC Immunology, 16(5).","DOI":"10.1186\/1471-2172-5-5"},{"issue":"4","key":"10001_CR82","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jvs.2005.11.019","volume":"43","author":"A Schepers","year":"2006","unstructured":"Schepers, A., et al. (2006). Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice. Journal of Vascular Surgery, 43(4), 809\u2013815.","journal-title":"Journal of Vascular Surgery"},{"key":"10001_CR83","doi-asserted-by":"crossref","unstructured":"Wang, X., et al. (1995). Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis, 115(1), 89\u201398.","DOI":"10.1016\/0021-9150(94)05503-B"},{"issue":"12","key":"10001_CR84","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.ATV.0000147766.68987.0d","volume":"24","author":"L Zhang","year":"2004","unstructured":"Zhang, L., et al. (2004). Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(12), 2277\u20132283.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10001_CR85","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/ATVBAHA.107.151613","volume":"28","author":"L Zhang","year":"2008","unstructured":"Zhang, L., et al. (2008). Tumor necrosis factor receptor-2 signaling attenuates vein graft neointima formation by promoting endothelial recovery. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(2), 284\u2013289.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"5","key":"10001_CR86","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.180.5.2886","volume":"180","author":"T Wang","year":"2008","unstructured":"Wang, T., et al. (2008). The role for monocyte chemoattractant protein-1 in the generation and function of memory CD8+ T cells. Journal of Immunology, 180(5), 2886\u20132893.","journal-title":"Journal of Immunology"},{"key":"10001_CR87","doi-asserted-by":"crossref","unstructured":"Schepers, A., et al. (2006). Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(9), 2063\u20132069.","DOI":"10.1161\/01.ATV.0000235694.69719.e2"},{"issue":"6","key":"10001_CR88","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jvs.2007.01.066","volume":"45","author":"H Tatewaki","year":"2007","unstructured":"Tatewaki, H., et al. (2007). Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. Journal of Vascular Surgery, 45(6), 1236\u20131243.","journal-title":"Journal of Vascular Surgery"},{"issue":"6","key":"10001_CR89","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jvs.2007.07.049","volume":"46","author":"SA Berceli","year":"2007","unstructured":"Berceli, S. A., et al. (2007). Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. Journal of Vascular Surgery, 46(6), 1173\u20131179.","journal-title":"Journal of Vascular Surgery"},{"issue":"37","key":"10001_CR90","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker, S., et al. (2014). 2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal, 35(37), 2541\u20132619.","journal-title":"European Heart Journal"},{"issue":"2","key":"10001_CR91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","volume":"28","author":"SV Deo","year":"2013","unstructured":"Deo, S. V., et al. (2013). Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis. Journal of Cardiac Surgery, 28(2), 109\u2013116.","journal-title":"Journal of Cardiac Surgery"},{"issue":"16","key":"10001_CR92","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2018.3197","volume":"319","author":"Q Zhao","year":"2018","unstructured":"Zhao, Q., et al. (2018). Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial. Jama, 319(16), 1677\u20131686.","journal-title":"Jama"},{"issue":"10","key":"10001_CR93","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","volume":"131","author":"A Kulik","year":"2015","unstructured":"Kulik, A., et al. (2015). Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation, 131(10), 927\u2013964.","journal-title":"Circulation"},{"issue":"4","key":"10001_CR94","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mtc.2001.111204","volume":"121","author":"A Ehsan","year":"2001","unstructured":"Ehsan, A., et al. (2001). Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. The Journal of Thoracic and Cardiovascular Surgery, 121(4), 714\u2013722.","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"9189","key":"10001_CR95","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(99)09405-2","volume":"354","author":"MJ Mann","year":"1999","unstructured":"Mann, M. J., et al. (1999). Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet, 354(9189), 1493\u20131498.","journal-title":"Lancet"},{"issue":"1","key":"10001_CR96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/153857440503900102","volume":"39","author":"MS Conte","year":"2005","unstructured":"Conte, M. S., et al. (2005). Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vascular and Endovascular Surgery, 39(1), 15\u201323.","journal-title":"Vascular and Endovascular Surgery"},{"issue":"4","key":"10001_CR97","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","volume":"43","author":"MS Conte","year":"2006","unstructured":"Conte, M. S., et al. (2006). Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. Journal of Vascular Surgery, 43(4), 742\u2013751 discussion 751.","journal-title":"Journal of Vascular Surgery"},{"issue":"3","key":"10001_CR98","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.vph.2012.10.008","volume":"58","author":"AC Bradshaw","year":"2013","unstructured":"Bradshaw, A. C., & Baker, A. H. (2013). Gene therapy for cardiovascular disease: perspectives and potential. Vascular Pharmacology, 58(3), 174\u2013181.","journal-title":"Vascular Pharmacology"},{"issue":"2","key":"10001_CR99","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/187152911798347043","volume":"11","author":"GM Lin","year":"2011","unstructured":"Lin, G. M. (2011). Pexelizumab, an anti-C5 complement antibody for primary coronary revascularization: a new insight from old versions. Cardiovascular & Hematological Disorders Drug Targets, 11(2), 97\u2013101.","journal-title":"Cardiovascular & Hematological Disorders Drug Targets"},{"issue":"4","key":"10001_CR100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jvs.2013.04.042","volume":"58","author":"M Sobel","year":"2013","unstructured":"Sobel, M., et al. (2013). Low levels of a natural IgM antibody are associated with vein graft stenosis and failure. Journal of Vascular Surgery, 58(4), 997\u20131005.e10052.","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"10001_CR101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2005.11.033","volume":"189","author":"JR Faria-Neto","year":"2006","unstructured":"Faria-Neto, J. R., et al. (2006). Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis, 189(1), 83\u201390.","journal-title":"Atherosclerosis"},{"key":"10001_CR102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fbioe.2018.00041","volume":"6","author":"M Carrabba","year":"2018","unstructured":"Carrabba, M., & Madeddu, P. (2018). Current strategies for the manufacture of small size tissue engineering vascular grafts. Frontiers in Bioengineering and Biotechnology, 6, 41.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"2","key":"10001_CR103","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/term.2977","volume":"14","author":"T Fukunishi","year":"2020","unstructured":"Fukunishi, T., et al. (2020). Different degradation rates of nanofiber vascular grafts in small and large animal models. Journal of Tissue Engineering and Regenerative Medicine, 14(2), 203\u2013214.","journal-title":"Journal of Tissue Engineering and Regenerative Medicine"},{"key":"10001_CR104","doi-asserted-by":"crossref","first-page":"119577","DOI":"10.1016\/j.biomaterials.2019.119577","volume":"229","author":"WJ Geelhoed","year":"2020","unstructured":"Geelhoed, W. J., et al. (2020). A novel method for engineering autologous non-thrombogenic in situ tissue-engineered blood vessels for arteriovenous grafting. Biomaterials, 229, 119577.","journal-title":"Biomaterials"},{"issue":"3","key":"10001_CR105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/SLA.0b013e318184dcbd","volume":"248","author":"MP Brennan","year":"2008","unstructured":"Brennan, M. P., et al. (2008). Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Annals of Surgery, 248(3), 7.","journal-title":"Annals of Surgery"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10001-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-020-10001-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10001-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T23:37:46Z","timestamp":1623800266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-020-10001-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10001"],"URL":"https:\/\/doi.org\/10.1007\/s12265-020-10001-y","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"23 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors. All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}